Tumor-associated autoantibodies as diagnostic and prognostic biomarkers
In the process of tumorigenesis, normal cells are remodeled to cancer cells and protein expression patterns are changed to those of tumor cells. A newly formed tumor microenvironment elicits the immune system and, as a result, a humoral immune response takes place. Although the tumor antigens are un...
Main Author: | Eun-Wie Cho |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society for Biochemistry and Molecular Biology
2012-12-01
|
Series: | BMB Reports |
Subjects: | |
Online Access: | http://www.jbmb.or.kr/jbmb/pdf.php?data=MTMwMTE0MTVAcGRmX3JhaW50cmFjZV9sZWV5c0AlNUI0NS0xMiU1RDEyMTIyNjE2MThfJTI4Njc3LTY4NSUyOUJNQl8xMi0yMzYucGRm |
Similar Items
-
Diagnostic value of tumor-associated autoantibodies panel in combination with traditional tumor markers for lung cancer
by: Yu Xu, et al.
Published: (2023-02-01) -
Autoantibody profiling of alveolar rhabdomyosarcoma patients unveils tumor-associated antigens with diagnostic and prognostic significance
by: Elena Poli, et al.
Published: (2021-01-01) -
Prognostic Value of Circulating IGFBP2 and Related Autoantibodies in Children with Metastatic Rhabdomyosarcomas
by: Elena Poli, et al.
Published: (2020-02-01) -
Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization
by: Jianying Zhang, et al.
Published: (2022-07-01) -
Comparing the clinical significance and antigen specificity of insulinoma‐associated antigen‐2 autoantibodies between radioimmunoassay and enzyme‐linked immunosorbent assay in Japanese patients with type 1 diabetes
by: Eiji Kawasaki, et al.
Published: (2023-01-01)